The stock of Annexon Inc (ANNX) has gone up by 4.14% for the week, with a 15.03% rise in the past month and a -41.33% drop in the past quarter. The volatility ratio for the week is 8.57%, and the volatility levels for the past 30 days are 8.99% for ANNX. The simple moving average for the past 20 days is 0.11% for ANNX’s stock, with a -61.78% simple moving average for the past 200 days.
Is It Worth Investing in Annexon Inc (NASDAQ: ANNX) Right Now?
The 36-month beta value for ANNX is also noteworthy at 1.20. There are mixed opinions on the stock, with 5 analysts rating it as a “buy,” 3 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for ANNX is 95.53M, and at present, short sellers hold a 9.71% of that float. The average trading volume of ANNX on May 15, 2025 was 1.69M shares.
ANNX) stock’s latest price update
Annexon Inc (NASDAQ: ANNX) has seen a rise in its stock price by 0.57 in relation to its previous close of 1.75. However, the company has experienced a 4.14% gain in its stock price over the last five trading sessions. globenewswire.com reported 2025-05-12 that FDA Meeting for Tanruprubart (formerly ANX005), the First Potential Targeted Therapy for GBS, Scheduled for Second Quarter 2025 Ahead of Planned BLA Submission
Analysts’ Opinion of ANNX
Many brokerage firms have already submitted their reports for ANNX stocks, with JP Morgan repeating the rating for ANNX by listing it as a “Overweight.” The predicted price for ANNX in the upcoming period, according to JP Morgan is $11 based on the research report published on March 01, 2024 of the previous year 2024.
BofA Securities, on the other hand, stated in their research note that they expect to see ANNX reach a price target of $6, previously predicting the price at $4. The rating they have provided for ANNX stocks is “Buy” according to the report published on December 21st, 2023.
Wells Fargo gave a rating of “Overweight” to ANNX, setting the target price at $11 in the report published on October 30th of the previous year.
ANNX Trading at -12.67% from the 50-Day Moving Average
After a stumble in the market that brought ANNX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -77.58% of loss for the given period.
Volatility was left at 8.99%, however, over the last 30 days, the volatility rate increased by 8.57%, as shares surge +14.29% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -28.74% lower at present.
During the last 5 trading sessions, ANNX rose by +4.14%, which changed the moving average for the period of 200-days by -71.79% in comparison to the 20-day moving average, which settled at $1.7578. In addition, Annexon Inc saw -65.69% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ANNX starting from Dananberg Jamie, who sale 5,521 shares at the price of $2.96 back on Feb 18 ’25. After this action, Dananberg Jamie now owns 33,479 shares of Annexon Inc, valued at $16,342 using the latest closing price.
ARTIS DEAN RICHARD, the EVP & CHIEF SCIENTIFIC OFFICER of Annexon Inc, sale 5,515 shares at $2.97 during a trade that took place back on Feb 18 ’25, which means that ARTIS DEAN RICHARD is holding 83,814 shares at $16,380 based on the most recent closing price.
Stock Fundamentals for ANNX
The total capital return value is set at -0.68. Equity return is now at value -66.13, with -55.14 for asset returns.
Based on Annexon Inc (ANNX), the company’s capital structure generated 0.1 points at debt to capital in total, while cash flow to debt ratio is standing at -4.94.
Currently, EBITDA for the company is -134.75 million with net debt to EBITDA at 0.38. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.99.
Conclusion
In summary, Annexon Inc (ANNX) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
